Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function

Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible fo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation research 1988-07, Vol.63 (1), p.126-134
Hauptverfasser: Lang, Roberto M, Carroll, John D, Nakamura, Shigeru, Itoh, Haruki, Rajfer, Sol I
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 134
container_issue 1
container_start_page 126
container_title Circulation research
container_volume 63
creator Lang, Roberto M
Carroll, John D
Nakamura, Shigeru
Itoh, Haruki
Rajfer, Sol I
description Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)
doi_str_mv 10.1161/01.RES.63.1.126
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78252659</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78252659</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</originalsourceid><addsrcrecordid>eNqFkUtv1DAQgC0EKtvCmROSD4hbUo-d2M6x6oMiLUJaHkcsxzuhBq-92Ikq_j0uu_TKwRp55psZ6RtCXgFrASScM2g3159aKVpogcsnZAU975quV_CUrBhjQ6OEYM_JaSk_GINO8OGEnAihhVCwIt82KSBNE73YZozJ4X5OuVAbt_Qq7e3OR6Qb_Jf2kX5I2yXY2cfvdI3TTL9inLN3NZfplbdlTsE7erNEN_sUX5Bnkw0FXx7jGflyc_358rZZf3z3_vJi3bhOdbyRI05yBAGWd9gDt1w46ZQckHdiYqx3Uy8568ZhUNhppZQWnMGo9ZYxzXpxRt4e5u5z-rVgmc3OF4ch2IhpKUZp3nPZD_8Fqz0tOX8Azw-gy6mUjJPZZ7-z-bcBZh7UGwamqjdSGDBVfe14fRy9jDvcPvJH17X-5li3xdkwZRudL4-Y0kypv4u7A3afwoy5_AzLPWZzhzbMd6ZelAkGvIFB14b6a-oDLv4Ad5SZzg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15286229</pqid></control><display><type>article</type><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</creator><creatorcontrib>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</creatorcontrib><description>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.RES.63.1.126</identifier><identifier>PMID: 3383371</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Animals ; Biological and medical sciences ; Diastole - drug effects ; Dobutamine - pharmacology ; Dogs ; Domperidone - pharmacology ; dopamine ; Dopamine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Heart ; Hemodynamics - drug effects ; Myocardial Contraction - drug effects ; Prazosin - analogs &amp; derivatives ; Prazosin - pharmacology ; Receptors, Adrenergic - physiology ; Receptors, Dopamine - physiology ; Systole - drug effects ; ventricle ; Ventricular Function ; Vertebrates: cardiovascular system ; Yohimbine - pharmacology</subject><ispartof>Circulation research, 1988-07, Vol.63 (1), p.126-134</ispartof><rights>1988 American Heart Association, Inc.</rights><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3687,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7807729$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3383371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lang, Roberto M</creatorcontrib><creatorcontrib>Carroll, John D</creatorcontrib><creatorcontrib>Nakamura, Shigeru</creatorcontrib><creatorcontrib>Itoh, Haruki</creatorcontrib><creatorcontrib>Rajfer, Sol I</creatorcontrib><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Diastole - drug effects</subject><subject>Dobutamine - pharmacology</subject><subject>Dogs</subject><subject>Domperidone - pharmacology</subject><subject>dopamine</subject><subject>Dopamine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart</subject><subject>Hemodynamics - drug effects</subject><subject>Myocardial Contraction - drug effects</subject><subject>Prazosin - analogs &amp; derivatives</subject><subject>Prazosin - pharmacology</subject><subject>Receptors, Adrenergic - physiology</subject><subject>Receptors, Dopamine - physiology</subject><subject>Systole - drug effects</subject><subject>ventricle</subject><subject>Ventricular Function</subject><subject>Vertebrates: cardiovascular system</subject><subject>Yohimbine - pharmacology</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1DAQgC0EKtvCmROSD4hbUo-d2M6x6oMiLUJaHkcsxzuhBq-92Ikq_j0uu_TKwRp55psZ6RtCXgFrASScM2g3159aKVpogcsnZAU975quV_CUrBhjQ6OEYM_JaSk_GINO8OGEnAihhVCwIt82KSBNE73YZozJ4X5OuVAbt_Qq7e3OR6Qb_Jf2kX5I2yXY2cfvdI3TTL9inLN3NZfplbdlTsE7erNEN_sUX5Bnkw0FXx7jGflyc_358rZZf3z3_vJi3bhOdbyRI05yBAGWd9gDt1w46ZQckHdiYqx3Uy8568ZhUNhppZQWnMGo9ZYxzXpxRt4e5u5z-rVgmc3OF4ch2IhpKUZp3nPZD_8Fqz0tOX8Azw-gy6mUjJPZZ7-z-bcBZh7UGwamqjdSGDBVfe14fRy9jDvcPvJH17X-5li3xdkwZRudL4-Y0kypv4u7A3afwoy5_AzLPWZzhzbMd6ZelAkGvIFB14b6a-oDLv4Ad5SZzg</recordid><startdate>198807</startdate><enddate>198807</enddate><creator>Lang, Roberto M</creator><creator>Carroll, John D</creator><creator>Nakamura, Shigeru</creator><creator>Itoh, Haruki</creator><creator>Rajfer, Sol I</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>M7Z</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>198807</creationdate><title>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</title><author>Lang, Roberto M ; Carroll, John D ; Nakamura, Shigeru ; Itoh, Haruki ; Rajfer, Sol I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4742-6bef6b131a24e512a23c6c769e243f005cf56204b997e4877783201b88d008053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Diastole - drug effects</topic><topic>Dobutamine - pharmacology</topic><topic>Dogs</topic><topic>Domperidone - pharmacology</topic><topic>dopamine</topic><topic>Dopamine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart</topic><topic>Hemodynamics - drug effects</topic><topic>Myocardial Contraction - drug effects</topic><topic>Prazosin - analogs &amp; derivatives</topic><topic>Prazosin - pharmacology</topic><topic>Receptors, Adrenergic - physiology</topic><topic>Receptors, Dopamine - physiology</topic><topic>Systole - drug effects</topic><topic>ventricle</topic><topic>Ventricular Function</topic><topic>Vertebrates: cardiovascular system</topic><topic>Yohimbine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lang, Roberto M</creatorcontrib><creatorcontrib>Carroll, John D</creatorcontrib><creatorcontrib>Nakamura, Shigeru</creatorcontrib><creatorcontrib>Itoh, Haruki</creatorcontrib><creatorcontrib>Rajfer, Sol I</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lang, Roberto M</au><au>Carroll, John D</au><au>Nakamura, Shigeru</au><au>Itoh, Haruki</au><au>Rajfer, Sol I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1988-07</date><risdate>1988</risdate><volume>63</volume><issue>1</issue><spage>126</spage><epage>134</epage><pages>126-134</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>Although both dopamine and dobutamine are potent positive inotropic agents, multiple studies indicate that dopamine may produce a rise in left ventricular (LV) filling pressure, while dobutamine often has the opposite effect. To ascertain the pharmacological and hemodynamic mechanisms responsible for the elevation in LV filling pressure observed with dopamine, we administered incremental infusions (2, 4, and 6 μg/kg/min) of dopamine to 18 open-chest, anesthetized dogs in the presence and absence of rauwolscine (selective α2-adrenoceptor antagonist) (n = 7), terazosin (selective α1-antagonist) (n = 6), and domperidone (selective dopamine2 antagonist) (n = 5), while measuring pressures in the LV and left atrium and changes in dimension in the LV short-axis (with ultrasonic piezo crystals). Dobutamine (2, 4, and 6 μg/kg/min) was infused in five additional dogs before and after administration of rauwolscine. The time constant of isovolumic pressure decay, peak lengthening rate (mm/sec), LV end-diastolic pressure, and diastolic pressure-dimension relation were computed. A significant elevation in LV end-diastolic pressure and a parallel increase in LV end-diastolic chamber size was observed with dopamine, while a decline in LV end-diastolic pressure occurred with dobutamine. Yet both dopamine and dobutamine caused a dose-related acceleration of pressure decay and augmentation of peak lengthening rate. Furthermore, heart rate declined during the administration of dopamine but rose with dobutamine. In the presence of either rauwolscine or terazosin, dopamine infusion resulted in a positive chronotropic effect and dose-dependent reductions in LV end-diastolic pressure and end-diastolic chamber dimension; arterial pressure fell only after terazosin administration. The hemodynamic actions of dobutamine, however, were unchanged in the presence of rauwolscine. Moreover, domperidone did not alter the hemodynamic responses to dopamine. The results of the present study suggest that activation of prejunctional α2-adrenoceptors and postjunctional α1- and α2-adrenoceptors play an important role in determining the hemodynamic responses to dopamine. The rise in LV filling pressure produced by dopamine can be attributed to venoconstriction resulting from stimulation of postjunctional α1- and α2-receptors. The decrease in heart rate observed with dopamine may also contribute toward the development of elevated LV filling pressures. (Circulation Research 1988;63:126-134)</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>3383371</pmid><doi>10.1161/01.RES.63.1.126</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7330
ispartof Circulation research, 1988-07, Vol.63 (1), p.126-134
issn 0009-7330
1524-4571
language eng
recordid cdi_proquest_miscellaneous_78252659
source MEDLINE; American Heart Association Journals; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Animals
Biological and medical sciences
Diastole - drug effects
Dobutamine - pharmacology
Dogs
Domperidone - pharmacology
dopamine
Dopamine - pharmacology
Fundamental and applied biological sciences. Psychology
Heart
Hemodynamics - drug effects
Myocardial Contraction - drug effects
Prazosin - analogs & derivatives
Prazosin - pharmacology
Receptors, Adrenergic - physiology
Receptors, Dopamine - physiology
Systole - drug effects
ventricle
Ventricular Function
Vertebrates: cardiovascular system
Yohimbine - pharmacology
title Role of Adrenoceptors and Dopamine Receptors in Modulating Left Ventricular Diastolic Function
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A09%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Adrenoceptors%20and%20Dopamine%20Receptors%20in%20Modulating%20Left%20Ventricular%20Diastolic%20Function&rft.jtitle=Circulation%20research&rft.au=Lang,%20Roberto%20M&rft.date=1988-07&rft.volume=63&rft.issue=1&rft.spage=126&rft.epage=134&rft.pages=126-134&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.RES.63.1.126&rft_dat=%3Cproquest_cross%3E78252659%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15286229&rft_id=info:pmid/3383371&rfr_iscdi=true